Screener
Insmed INSM Reportable Segment — Other segment items
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Insmed in its filing.
Tagged under the XBRL concept us-gaap:OtherCostAndExpenseOperating.
The source filing: Insmed’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104506-26-000041
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other external R&D expenses | 48,836 | 28,445 | 81,514 | 56,528 |
| R&D compensation and benefit-related expenses | 69,080 | 56,389 | 141,220 | 109,947 |
| SG&A compensation and benefit-related expenses | 70,520 | 51,320 | 145,313 | 106,156 |
| Other segment items(a) | 207,425 | 127,650 | 417,913 | 247,345 |
| Depreciation | 3,179 | 2,484 | 6,113 | 4,367 |
| Amortization of intangible assets | 2,081 | 1,263 | 4,162 | 2,526 |
| Change in fair value of contingent consideration | (99,760) | 59,000 | (146,721) | 77,300 |
| Investment income | (10,979) | (13,225) | (23,019) | (27,131) |
Item 1C. Consolidated Financial Statements
FAQ
- What is Insmed's reportable segment — other segment items?
- Insmed (INSM) reported reportable segment — other segment items of $207.43M in Q2 2026.
- How has Insmed's reportable segment — other segment items changed year-over-year?
- Insmed's reportable segment — other segment items increased by 62.5% year-over-year, from $127.65M to $207.43M.
- What is the long-term trend for Insmed's reportable segment — other segment items?
- Over 3 years (2022 to 2025), Insmed's reportable segment — other segment items has grown at a 34.5% compound annual growth rate (CAGR), from $231.71M to $563.93M.
- What does reportable segment — other segment items mean?
- This captures miscellaneous operational expenses or income items specific to the reportable segment that do not fall into standard categories like R&D or SG&A. It is often used for segment-specific overhead or non-recurring operational costs.
Ask your AI about Insmed's reportable segment — other segment items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude